Literature DB >> 875076

Non-Hodgkin's lymphoma in Ibadan, Nigeria.

O A Oluboyede, W A Olaofe, G J Esan.   

Abstract

One hundred patients with non-Hodgkin's lymphoma were admitted to the University College Hospital in Ibadan, Nigeria between 1960 and 1975. Their cases have been analyzed with respect to clinical findings, histological classification, and response to therapy. There was a preponderance of males over females (2:1) and the majority of the patients (87 percent) had reticulum cell sarcoma. Therapy consisted mainly of single-agent chemotherapy but a few patients had either surgical excision combined with chemotherapy or multiple-agent chemotherapy. The results of treatment were poor because of the very high default rate, late presentation, inadequate supply of drugs, and lack of radiotherapeutic facilities.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875076      PMCID: PMC2536930     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

1.  The interrelationship of Hodgkin's disease and other lymphatic tumors.

Authors:  R P CUSTER; W G BERNHARD
Journal:  Am J Med Sci       Date:  1948-12       Impact factor: 2.378

2.  Combination chemotherapy of advanced lymphocytic lymphoma. Importance of histologic classification in evaluating response.

Authors:  A T Skarin; G S Pinkus; R L Myerowitz; Y M Bishop; W C Moloney
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma.

Authors:  P S Schein; B A Chabner; G P Canellos; R C Young; C Berard; V T DeVita
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

4.  Histologic classification of Hodgkin's disease in the Western State of Nigeria.

Authors:  G M Edington; B O Osunkoya; M Hendrickse
Journal:  J Natl Cancer Inst       Date:  1973-06       Impact factor: 13.506

5.  Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.

Authors:  J K Luce; J F Gamble; H E Wilson; R W Monto; B L Isaacs; R L Palmer; C A Coltman; J S Hewlett; E A Gehan; E Frei
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

6.  Adult Hodgkin's disease in Uganda.

Authors:  C L Olweny; J L Ziegler; C W Berard; A C Templeton
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

7.  Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.

Authors:  C M Bagley; V T Devita; C W Berard; G P Canellos
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

8.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

9.  The therapy of Hodgkin's disease in Nigeria: a five year study.

Authors:  O A Oluboyede; G J Esan
Journal:  Afr J Med Med Sci       Date:  1976-09

10.  Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma.

Authors:  B Hoogstraten; A H Owens; R E Lenhard; O J Glidewell; L A Leone; K B Olson; J B Harley; S R Townsend; S Miller; C L Spurr
Journal:  Blood       Date:  1969-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.